These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35439167)

  • 21. The Hematopoietic Microenvironment in Myeloproliferative Neoplasms: The Interplay Between Nature (Stem Cells) and Nurture (the Niche).
    Zhan H; Kaushansky K
    Adv Exp Med Biol; 2020; 1273():135-145. PubMed ID: 33119879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.
    Chagraoui H; Komura E; Tulliez M; Giraudier S; Vainchenker W; Wendling F
    Blood; 2002 Nov; 100(10):3495-503. PubMed ID: 12393681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology.
    Eran Z; Zingariello M; Bochicchio MT; Bardelli C; Migliaccio AR
    F1000Res; 2019; 8():. PubMed ID: 31583083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis.
    Zingariello M; Martelli F; Ciaffoni F; Masiello F; Ghinassi B; D'Amore E; Massa M; Barosi G; Sancillo L; Li X; Goldberg JD; Rana RA; Migliaccio AR
    Blood; 2013 Apr; 121(17):3345-63. PubMed ID: 23462118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
    Teodorescu P; Pasca S; Jurj A; Gafencu G; Joelsson JP; Selicean S; Moldovan C; Munteanu R; Onaciu A; Tigu AB; Buse M; Zimta AA; Stiufiuc R; Petrushev B; Desmirean M; Dima D; Vlad C; Bergthorsson JT; Berce C; Ciurea S; Ghiaur G; Tomuleasa C
    J Cell Mol Med; 2020 Oct; 24(19):11100-11110. PubMed ID: 32889753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.
    Gleitz HF; Kramann R; Schneider RK
    J Pathol; 2018 Jun; 245(2):138-146. PubMed ID: 29570794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis.
    Lucijanic M; Livun A; Tomasovic-Loncaric C; Stoos-Veic T; Pejsa V; Jaksic O; Prka Z; Kusec R
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):523-526. PubMed ID: 27381374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.
    Agarwal A; Morrone K; Bartenstein M; Zhao ZJ; Verma A; Goel S
    Stem Cell Investig; 2016; 3():5. PubMed ID: 27358897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.
    Kaushansky K; Zhan H
    Adv Biol Regul; 2018 Aug; 69():11-15. PubMed ID: 29970351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for organ-specific stem cell microenvironments.
    Ghinassi B; Martelli F; Verrucci M; D'Amore E; Migliaccio G; Vannucchi AM; Hoffman R; Migliaccio AR
    J Cell Physiol; 2010 May; 223(2):460-70. PubMed ID: 20112287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor.
    Pecquet C; Staerk J; Chaligné R; Goss V; Lee KA; Zhang X; Rush J; Van Hees J; Poirel HA; Scheiff JM; Vainchenker W; Giraudier S; Polakiewicz RD; Constantinescu SN
    Blood; 2010 Feb; 115(5):1037-48. PubMed ID: 19996410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic ablation of Pim1 or pharmacologic inhibition with TP-3654 ameliorates myelofibrosis in murine models.
    Dutta A; Nath D; Yang Y; Le BT; Rahman MF; Faughnan P; Wang Z; Stuver M; He R; Tan W; Hutchison RE; Foulks JM; Warner SL; Zang C; Mohi G
    Leukemia; 2022 Mar; 36(3):746-759. PubMed ID: 34741118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathomechanism and clinical impact of myelofibrosis in neoplastic diseases of the bone marrow].
    Bedekovics J; Méhes G
    Orv Hetil; 2014 Mar; 155(10):367-75. PubMed ID: 24583557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis.
    Le Bousse-Kerdilès MC; Martyré MC;
    Pathol Biol (Paris); 2001 Mar; 49(2):153-7. PubMed ID: 11317961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis.
    Pizzi M; Gergis U; Chaviano F; Orazi A
    Hematol Oncol Stem Cell Ther; 2016 Sep; 9(3):96-104. PubMed ID: 27521149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells.
    Johnston JB; Dalal BI; Israels SJ; Oh S; McMillan E; Begleiter A; Michaud G; Israels LG; Greenberg AH
    Am J Clin Pathol; 1995 May; 103(5):574-82. PubMed ID: 7741102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
    Martyré MC
    Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis.
    Vannucchi AM; Bianchi L; Paoletti F; Pancrazzi A; Torre E; Nishikawa M; Zingariello M; Di Baldassarre A; Rana RA; Lorenzini R; Alfani E; Migliaccio G; Migliaccio AR
    Blood; 2005 May; 105(9):3493-501. PubMed ID: 15665119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
    Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
    Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.